India’s drug regulator CDSCO has asked pharmaceutical companies to stop promotional or awareness campaigns linked to GLP-1 obesity drugs
Go to Source
Author: News18
Go to Source
Author: News18
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
